{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:44:39Z","timestamp":1780454679378,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.tracli.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T09:40:12Z","timestamp":1699436412000},"page":"36-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre"],"prefix":"10.1016","volume":"31","author":[{"given":"Suhasini","family":"Sil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin K","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-7342","authenticated-orcid":false,"given":"Daljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2023.11.001_b0005","series-title":"Williams hematology, 9e","year":"2015"},{"key":"10.1016\/j.tracli.2023.11.001_b0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 Evidence-based approach from the writing committee of the American society for apheresis: The eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2023.11.001_b0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1442-2042.2004.00872.x","article-title":"Priapism secondary to leukemia: Effective management with prompt leukapheresis","volume":"11","author":"Ponniah","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.tracli.2023.11.001_b0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.tracli.2023.11.001_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.2012.09151.x","article-title":"How I manage priapism in chronic myeloid leukaemia patients","volume":"158","author":"Rodgers","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.tracli.2023.11.001_b0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1756287214542096","article-title":"Management of priapism: an update for clinicians","volume":"6","author":"Levey","year":"2014","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.tracli.2023.11.001_b0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11934-006-0061-6","article-title":"Priapism: new concepts in the pathophysiology and new treatment strategies","volume":"7","author":"Bivalacqua","year":"2006","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.tracli.2023.11.001_b0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s002770000199","article-title":"Treatment of long-lasting priapism in chronic myeloid leukemia at onset","volume":"79","author":"Morano","year":"2000","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.tracli.2023.11.001_b0045","first-page":"288","article-title":"Priapism\u2013a rare presentation inchronic myeloid leukemia: case report and review of theliterature","volume":"26","author":"Chang","year":"2003","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.tracli.2023.11.001_b0050","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.53365.1","article-title":"Case report: Priapism as the clinical presenting feature of chronic myeloid leukemia: Case report and 20-year literature review","volume":"10","author":"Bintoro","year":"2021","journal-title":"F1000Research"},{"key":"10.1016\/j.tracli.2023.11.001_b0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4103\/ijmpo.ijmpo_234_18","article-title":"Priapism in chronic myeloid leukemia: Meeting at the crossroads and heading in different directions","volume":"41","author":"Mishra","year":"2020","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"3","key":"10.1016\/j.tracli.2023.11.001_b0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jsm.12812","article-title":"Priapism as a result of chronic myeloid leukemia: case report, pathology, and review of the literature","volume":"12","author":"Shaeer","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.tracli.2023.11.001_b0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.transci.2012.03.012","article-title":"Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia","volume":"46","author":"Veljkovic","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.tracli.2023.11.001_b0070","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/jha2.545","article-title":"The value of leukapheresis for treatment of priapism as presenting feature of chronic myeloid leukemia-Case report and review of literature","volume":"3","author":"van der Velde","year":"2022","journal-title":"EJHaem"},{"issue":"3","key":"10.1016\/j.tracli.2023.11.001_b0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/pbc.21628","article-title":"Conservative management of priapism secondary to leukemia","volume":"51","author":"Castagnetti","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.tracli.2023.11.001_b0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1542\/pir.2017-0051","article-title":"Case 3: priapism in a 13-year-old boy","volume":"39","author":"Clark","year":"2018","journal-title":"Pediatr Rev"},{"issue":"1","key":"10.1016\/j.tracli.2023.11.001_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1188\/07.CJON.23-25","article-title":"Priapism in the oncology setting","volume":"11","author":"Manuel","year":"2007","journal-title":"Clin J Oncol Nurs"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782023005426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782023005426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:53:51Z","timestamp":1707353631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782023005426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1246782023005426"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2023.11.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}